| Serial Number | 79223972 |
| Word Mark | ONCOSIGNATURE |
| Filing Date | Friday, September 22, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 9, 2019 |
| Registration Number | 5718472 |
| Registration Date | Tuesday, April 9, 2019 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 22, 2019 |
| Description of Mark | The mark consists of the stylized wording "ONCOSIGNATURE" with "ONCO" in orange and "SIGNATURE" in blue. Above the wording are two interlocked circles, each consisting of an outer border of small blue circles and an inner layer of larger orange circles. |
| Goods and Services | Pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; medical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; veterinary pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; pharmaceutical and medical preparations for treatment, prevention and alleviation of cancer; pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; biological preparations for medical and veterinary purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; chemical preparations for therapeutic use, namely, for pharmaceutical or medical purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy prediction and/or analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits and does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes |
| Indication of Colors claimed | The color(s) orange and blue is/are claimed as a feature of the mark. |
| Goods and Services | Scientific and technological research and consultation services, namely, in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, drug repurposing, and identification of rational drug combinations; industrial analysis and research services, namely, industrial research in the field of oncology; basic medical research and medical clinical research, hereunder for development of therapeutics; drug discovery services; consultancy in the field of pharmaceutical research and development; medical and scientific research related to cancer and cancer therapy, including research related to treatment, prevention and alleviation of cancer; pharmaceutical research services related to prediction of drug treatment efficacy; medical research services related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction; medical research, namely, analysis related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Acrivon Therapeutics Inc. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | US |
| Party Name | OncoSignature AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Lund SE22381 SE |
| Party Name | OncoSignature AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lund SE223 81 SE |
| Party Name | OncoSignature AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lund SE223 81 SE |
| Event Date | Event Description |
| Tuesday, April 9, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Saturday, February 26, 2022 | CHANGE OF OWNER RECEIVED FROM IB |
| Tuesday, July 13, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, July 13, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 13, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, July 13, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 13, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 13, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, August 16, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, July 31, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, July 31, 2019 | FINAL DISPOSITION PROCESSED |
| Tuesday, July 9, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, April 9, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Friday, January 25, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 25, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, January 25, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 22, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 22, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 9, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 9, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 2, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, December 17, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 13, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, December 13, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 13, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 13, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 27, 2018 | ASSIGNED TO EXAMINER |
| Friday, August 3, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 3, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 2, 2018 | ASSIGNED TO LIE |
| Wednesday, July 18, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, February 3, 2018 | REFUSAL PROCESSED BY IB |
| Thursday, January 18, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 18, 2018 | REFUSAL PROCESSED BY MPU |
| Saturday, January 6, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, January 6, 2018 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 5, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 2, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, January 2, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 28, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |